Health News Releases

  • Today May 14
December 16, 2021 15:30
Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today announced the divestment of its finished drug product manufacturing business to CordenPharma, a full-service
December 15, 2021 16:30
PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the closing of the previously announced acquisition of Lyophilization Services o
December 15, 2021 13:50
BostonGene and NEC Announce Global Partnership
BostonGene Corporation and NEC Corporation (NEC; TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer BostonGene Tumor PortraitTM Tests in key in
December 14, 2021 17:05
CSL Limited announces tender offer to acquire Vifor Pharma Ltd
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Global biotechnology leader CSL Limited (ASX: CSL; USOTC:CSLLY) and Vifor Pharma Ltd (SIX:VIFN; ISIN:CH0364749348), a global specialty
December 14, 2021 17:00
Retrace AV Launches New Paint Product That Destroys SARS-CoV-2, the COVID-19 Virus Within 30 Minutes
Billions of people around the world are attempting to return to workplaces, schools and social spaces. Governments & business owners need to do everything they can to boost confidence and let consumer
December 14, 2021 11:30
Organon Completes Acquisition of Forendo Pharma
Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in
December 14, 2021 11:10
New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Anesthesia & Analgesia in which Dr. Claudia Spies and colleagues investigated the relationship between parameters
December 13, 2021 17:31
Vifor Pharma comments on media speculation
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor is in discussions with CSL about a possible transaction. No decisions have been made yet and there is no time frame for this. Un
December 13, 2021 14:49
KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
KOREA PACK and concurrent event ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022. KOREA PACK and ICPI WEEK, the largest packaging, cosmetic and phar
December 13, 2021 14:35
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult pat
December 13, 2021 10:00
Researchers to Investigate the Gut-Brain Axis in Soldiers With Microba’s Technology
Leading Australian universities will explore the ‘cognobiome’ of soldiers using Microba Life Science’s analysis platform to discover opportunities for improving cognitive and physiological performance
December 10, 2021 16:25
Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today announced the appointment of Hervé Gisserot as Chief Commercial Officer and member of the Vifor Pharma Execut
December 10, 2021 16:20
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN) today announced results from the exploratory phase-II GUARD trial of Angion’s A
December 10, 2021 11:40
Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership
December 09, 2021 13:20
Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the data from the pivotal Phase 3 SOLSTICE clinical trial of LIVTENCITY™ (maribavir, TAK-620) in post-transpla
December 08, 2021 20:00
Aleph Farms and WACKER Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat
Aleph Farms, the first cultivated meat company to grow steaks directly from non-genetically engineered animal cells and WACKER, a supplier of leading protein production technologies, today announced t
December 08, 2021 16:00
Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd American Society of Hematology (ASH) Annual Meeting
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present a total of 23 company-sponsored abstracts at the 63rd American Society of Hematology (ASH) Ann
December 08, 2021 11:30
Longevity Science Foundation Launches Decentralised Blockchain Voting Programme
The Longevity Science Foundation (LSF) — a Swiss non-profit dedicated to advancing the healthy human lifespan — has announced today it will use blockchain technology in its funding selection process.
December 08, 2021 10:05
Maria Teresa Hilado to Join Galderma’s Advisory Committee
Galderma, the world’s largest independent dermatology company, announced today that Maria Teresa “Tessa” Hilado will join its Advisory Committee, effective January 1, 2022. Ms. Hilado currently ser
December 07, 2021 13:50
Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling
Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed the Single Cellome™ System SS2000, a single-cell analysis solution that utilizes high-resolution images captured with a confo
December 07, 2021 09:35
Galderma Announces New Data Demonstrating the Positive Anti-inflammatory Effect and Mode of Action of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Galderma today announced that the Journal of Allergy and Clinical Immunology has published gene expression data that demonstrate the positive anti-inflammatory effect and mode of action of nemolizumab
December 06, 2021 17:00
PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, announces today the completion of its Series B2 round of financing.
December 03, 2021 23:15
Healthcare+ Expo Taiwan to Build an Ecosystem of Digital Transformation in Healthcare
One of the largest trade fairs in the APAC region- the Healthcare+ Expo Taiwan- takes place on 2 to 5 December in Taipei. The Expo displays Taiwan’s strength in AI, Cloud-based Applications, Flat Pane
December 03, 2021 11:50
Vifor Pharma comments on market speculations
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Due to current market speculations, Vifor Pharma Group states the following: Vifor Pharma Group systematically reviews options that
December 02, 2021 11:35
LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that the fir
25 per page50 per page75 per page100 per page